Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinuclidine, 1-azabicyclo[2.2.1]heptane, 1-azabicyclo [3.2.1]octane, and 1-azabicyclo[3.2.2]nonane compounds as alpha-7 nicotinic acetylcholine receptor ligands

Quinuclidine, 1-azabicyclo[2.2.1]heptane, 1-azabicyclo [3.2.1]octane, and 1-azabicyclo[3.2.2]nonane compounds as alpha-7 nicotinic acetylcholine receptor ligands

US Patent 9458179 · Granted Oct 4, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tricyclic compounds2024
Tricyclic compounds2022
Isofuranone compounds useful as HPK1 inhibitors2021
Tricyclic compounds as anticancer agents2020
Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands2019
Tricyclic compounds as anticancer agents2017
Tricyclic compounds as anticancer agents2017
Tricyclic compounds as anticancer agents2017
Oxazolidinones as modulators of mGluR52017
Oxazolidinones as modulators of mGluR52017
Aza-bicyclic amine N-oxide compounds as alpha-7 nicotinic acetylcholine receptor2013
Aza-bicyclic amine N-oxide compounds as alpha-7 nicotinic acetylcholine receptor2013